Thermo Fisher Scientific Inc.
TMO
$512.69
$4.590.90%
NYSE
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.20% | 4.94% | 2.97% | 0.18% | 4.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.20% | 4.94% | 2.98% | 0.18% | 4.68% |
| Cost of Revenue | 9.46% | 4.28% | 3.99% | -0.11% | 1.24% |
| Gross Profit | 4.13% | 5.90% | 1.54% | 0.62% | 9.72% |
| SG&A Expenses | 2.71% | 1.15% | -2.30% | -4.62% | 3.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -550.00% | -- | -- | -- | 2,900.00% |
| Total Operating Expenses | 5.43% | 3.36% | 2.41% | -1.11% | 2.68% |
| Operating Income | 14.32% | 12.13% | 5.67% | 6.67% | 13.61% |
| Income Before Tax | 7.55% | 5.73% | 1.72% | -0.43% | 13.51% |
| Income Tax Expenses | 2.00% | 109.09% | -28.13% | -66.19% | 12.78% |
| Earnings from Continuing Operations | 8.00% | -0.55% | 4.18% | 13.44% | 13.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -200.00% | -- | 66.67% | 0.00% | -75.00% |
| Net Income | 7.32% | -0.86% | 4.46% | 13.48% | 12.27% |
| EBIT | 14.32% | 12.13% | 5.67% | 6.67% | 13.61% |
| EBITDA | 10.32% | 5.75% | 0.00% | -0.62% | 6.15% |
| EPS Basic | 9.03% | 0.19% | 5.56% | 14.68% | 13.74% |
| Normalized Basic EPS | 11.86% | 13.08% | 9.00% | 4.90% | 16.23% |
| EPS Diluted | 9.28% | 0.47% | 5.89% | 15.03% | 13.81% |
| Normalized Diluted EPS | 11.86% | 13.67% | 9.28% | 5.17% | 16.23% |
| Average Basic Shares Outstanding | -1.57% | -1.05% | -1.05% | -1.05% | -1.29% |
| Average Diluted Shares Outstanding | -1.57% | -1.56% | -1.31% | -1.30% | -1.29% |
| Dividend Per Share | 10.26% | 10.26% | 10.26% | 10.26% | 11.43% |
| Payout Ratio | 0.01% | 0.10% | 0.04% | -0.03% | -0.02% |